Skip to main content

Table 4 Comparison of background characteristics by dexamethasone treatment of patients treated as bacterial meningitis in Ethiopia, 2011–2015

From: Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking?

Characteristics

Dexamethasone

No dexamethasone

P value

Mean age, year (SD)

30.1 (15.0)

33.9 (16.2)

0.116

Duration of illness, days (SD)

5.2 (4.3)

5.0 (4.3)

0.683

Diagnosis of meningitis

 Confirmed

12 (85.7)

2 (14.3)

0.001*

 Probable

51 (62.2)

31 (37.8)

 Suspected

84 (42.9)

112 (57.1)

 Non-cases

67 (50.4)

66 (49.6)

Prior antibiotic treatment

 Yes

45 (43.3)

59 (56.7)

0.096

 No

169 (52.6)

152 (47.4)

Impairment of consciousness

 Yes

102 (52.0)

94 (48)

0.52

 No

112 (48.9)

117 (51.1)

Focal neurologic deficit

 Yes

22 (66.7)

11 (33.3)

0.051

 No

192 (49.0)

200 (51.0)

CSF appearance

 Turbid

37 (64.9)

20 (35.1)

<0.001*

 Normal

68 (38.2)

110 (61.8)

Detection of organism by Gram stain

 Yes

11 (84.6)

2 (15.4)

0.003*

 No

89 ((43.0)

118 (57.0)

HIV status

 Positive

7 (30.4)

16 (69.6)

0.048*

 Negative

207 (51.6)

194 (48.4)

Hospital

 Jimma

52 (42.6)

70 (57.4)

<0.001

 Gondar

24 (26.1)

68 (73.9)

 Hawassa

65 (76.5)

20 (23.5)

 Arba Minch

73 (57.9)

53 (42.1)

  1. *statistically significant